Gennova Biopharmaceuticals, in partnership with CEPI, will advance the development of a self-amplifying mRNA vaccine against ...
Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...
Currently there are no authorized vaccines or targeted drugs against Nipah, which kills an estimated 75% of those it infects.
Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...
Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...
UKHSA has revealed the most dangerous pathogens for Britain as one scientist warns a measles-like virus would ‘pose a threat ...
Explore more
Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on ...
8d
GlobalData on MSNUKHSA unveils high-risk pathogen list to drive innovationThe agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.
Thiruvananthapuram: Chief Minister Pinarayi Vijayan stated that the Union Government has denied Kerala an All India Institute ...
Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results